The drop in reported invasive pneumococcal disease among adults during the first COVID-19 wave in the Netherlands explained.
COVID-19
IPD
Pandemic
S. pneumoniae
Surveillance
Journal
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
ISSN: 1878-3511
Titre abrégé: Int J Infect Dis
Pays: Canada
ID NLM: 9610933
Informations de publication
Date de publication:
Oct 2021
Oct 2021
Historique:
received:
01
08
2021
revised:
22
08
2021
accepted:
23
08
2021
pubmed:
30
8
2021
medline:
8
10
2021
entrez:
29
8
2021
Statut:
ppublish
Résumé
Streptococcus pneumoniae is the leading bacterial pathogen causing respiratory infections. Since the COVID-19 pandemic emerged, less invasive pneumococcal disease (IPD) was identified by surveillance systems worldwide. Measures to prevent transmission of SARS-CoV-2 also reduce transmission of pneumococci, but this would gradually lead to lower disease rates. Here, we explore additional factors contributing to the instant drop in pneumococcal disease cases captured in surveillance. Our observations on referral practices and other impediments to diagnostic testing indicate that residual IPD has likely occurred but remained undetected by conventional hospital-based surveillance. Depending on the setting, we discuss alternative monitoring strategies that could improve understanding of pneumococcal disease dynamics.
Identifiants
pubmed: 34455081
pii: S1201-9712(21)00691-3
doi: 10.1016/j.ijid.2021.08.060
pmc: PMC8444629
pii:
doi:
Substances chimiques
Pneumococcal Vaccines
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
196-203Informations de copyright
Copyright © 2021 The Authors. Published by Elsevier Ltd.. All rights reserved.
Références
Ned Tijdschr Geneeskd. 2020 Jun 3;164:
pubmed: 32749807
Eur J Clin Microbiol Infect Dis. 2014 Jul;33(7):1119-24
pubmed: 24449347
Am J Med. 1999 Apr;106(4):385-90
pubmed: 10225239
Lancet. 2009 Oct 31;374(9700):1543-56
pubmed: 19880020
PLoS One. 2018 Mar 30;13(3):e0194823
pubmed: 29601605
J Pediatr. 1996 Feb;128(2):190-5
pubmed: 8636810
J Infect Chemother. 2015 Sep;21(9):672-9
pubmed: 26212866
Clin Infect Dis. 2017 Jun 15;64(suppl_3):S368-S377
pubmed: 28575366
BMC Infect Dis. 2015 Feb 13;15:56
pubmed: 25885896
Clin Microbiol Infect. 2014 Dec;20(12):O1145-51
pubmed: 24995531
Lancet Respir Med. 2020 Jul;8(7):687-695
pubmed: 32386571
Scand J Infect Dis. 2012 Jun;44(6):433-8
pubmed: 22263905
BMC Infect Dis. 2021 Feb 12;21(1):173
pubmed: 33579205
Am J Respir Crit Care Med. 2014 May 15;189(10):1204-13
pubmed: 24635548
Pediatr Infect Dis. 1986 Nov-Dec;5(6):626-32
pubmed: 3491977
Lancet Infect Dis. 2004 Mar;4(3):144-54
pubmed: 14998500
J Infect. 2020 Aug;81(2):266-275
pubmed: 32473235
Crit Care Med. 2006 Feb;34(2):344-53
pubmed: 16424713
Crit Care. 2015 Sep 07;19:319
pubmed: 26346055
Clin Infect Dis. 2019 Jan 1;68(1):61-69
pubmed: 29788414
Nat Rev Microbiol. 2014 Apr;12(4):252-62
pubmed: 24590244
Emerg Infect Dis. 2012 Feb;18(2):294-7
pubmed: 22305270
Vaccine. 2021 Feb 12;39(7):1039-1043
pubmed: 33478793
J Med Microbiol. 2011 Jun;60(Pt 6):710-714
pubmed: 21349984
Nat Rev Dis Primers. 2016 Nov 03;2:16074
pubmed: 27808261
Neth J Med. 2013 Dec;71(10):502-7
pubmed: 24394734
Clin Vaccine Immunol. 2014 Jun;21(6):904-7
pubmed: 24759650
Am J Respir Crit Care Med. 2021 Mar 1;203(5):604-613
pubmed: 32941735
Infect Dis (Lond). 2021 Feb;53(2):102-110
pubmed: 33103530
Lancet Digit Health. 2021 Jun;3(6):e360-e370
pubmed: 34045002
Med Princ Pract. 2015;24(2):189-94
pubmed: 25613456
Scand J Infect Dis. 2008;40(9):715-20
pubmed: 19086245
Int J Infect Dis. 2005 Sep;9(5):274-9
pubmed: 16095941
Lancet Infect Dis. 2018 Nov;18(11):1191-1210
pubmed: 30243584
Pediatrics. 2020 Aug;146(2):
pubmed: 32457213
ERJ Open Res. 2020 Jan 10;6(1):
pubmed: 31956656
Virus Res. 2020 Aug;285:198005
pubmed: 32408156
N Engl J Med. 2015 Apr 2;372(14):1312-23
pubmed: 25830421
Disaster Med Public Health Prep. 2020 Aug 12;:1-4
pubmed: 32782063
Pediatr Emerg Care. 1994 Oct;10(5):268-72
pubmed: 7845852